The etiologic factors of late-life depression are still poorly understood. Recent evidence suggests that microvascular dysfunction is associated with depression, which may have implications for prevention and treatment. However, this association has not been systematically reviewed.
L ate-life depression is a highly prevalent and heterogeneous disease with high rates of morbidity and mortality. 1, 2 It is characterized by recurrent episodes: up to 50% of those who recover from a first episode of depression will experience additional episodes throughout their lifetime. [3] [4] [5] [6] Evidence suggests a cerebrovascular etiologic cause 7 because late-life depression has been associated with vascular dementia, stroke, and white matter hyperintensities (WMHs). 8 Moreover, a vascular etiologic cause may explain the high recurrence rate of depression, in addition to the high rate of resistance to antidepressants and/or cognitive behavioral therapy; approximately one-third of patients with depression have treatment-resistant depression. 6, 9, 10 Several studies have provided evidence that cerebral small vessel disease may play a role in the etiologic factors of latelife depression. 7, [11] [12] [13] [14] [15] [16] [17] [18] A meta-analysis from 2014, including 19 studies and 6274 participants, showed significant crosssectional and longitudinal associations between white matter lesions, a proxy of cerebral small vessel disease, and (incident) depression. 19 However, multiple studies with continuous measures of WMHs were not included in this meta-analysis, and 2 large longitudinal studies became available only recently. 13, 20 Furthermore, the growing evidence on alternative markers of microvascular dysfunction (for instance, on biomarkers of endothelial dysfunction) was not taken into account in previous meta-analyses. [21] [22] [23] In view of these considerations, we hypothesize that microvascular dysfunction, both peripheral and cerebral, may be associated with depression. We conducted a systematic review and meta-analysis to investigate this hypothesis, both in cross-sectional and longitudinal studies.
Methods

Search Strategy
We used MEDLINE and EMBASE to conduct a systematic literature search for cross-sectional and longitudinal epidemiologic studies of humans, determining the association between markers of microvascular dysfunction and depressive symptoms and/or depressive disorder, published from inception to October 16, 2016 . This study has been registered at PROSPERO (https://www.crd.york.ac.uk/PROSPERO/ [CRD42016049158]) and is reported in accordance with the PRISMA 24 and MOOSE guidelines. We considered the following 5 estimates of microvascular dysfunction: plasma markers of endothelial function, albuminuria, measurements of skin and muscle microcirculation, retinal arteriolar and venular diameter, and markers for cerebral small vessel disease. The exact search strategy and rationale are in the eAppendix in the Supplement.
Selection Criteria and Data Extraction
Three independent researchers performed the study selection (M.J.M.v.A., A.J.H.M.H., and M.T.S.). Population-based or case-control studies that reported on microvascular dysfunction in participants with or without depression were included. Figure 1 shows the selection procedure. Of the 67 studies included in the review, we extracted the following: baseline characteristics of the study population, study design, number of participants with or without depression, definition of microvascular dysfunction and depression (self-reported questionnaire vs diagnostic psychiatric interview), fully adjusted results including 95% CIs, SD, or range, and confounders included in the analyses. When these data were missing, the principal investigators were contacted for further information. If the principal investigator could not provide the missing data, the study was excluded. The quality of studies was assessed by use of the Newcastle-Ottawa Scale (NOS) for case-control and cohort studies (eTable 1 in the Supplement). This scale uses a 10-point grading system with a maximum score of 9 points for longitudinal studies, 6 points for cross-sectional cohort studies, and 8 points for case-control studies and assesses selection of study groups, comparability of groups, and ascertainment of exposure and outcome. 25 We calculated the percentage of the maximum NOS score for all studies (eTable 1 in the Supplement).
(diagnostic interviews vs self-reported questionnaires), study design (case-control vs cohort study), methods to assess WMHs (semiautomatic volumetry vs subjective rating scale), and study quality as assessed by the NOS score (≥60% vs <60%).
Results
Study Selection and Characteristics
We identified 712 studies, of which 90 full-text articles were assessed for eligibility. Of these, we selected 67 studies that investigated whether microvascular dysfunction was associated with depressive disorder or depressive symptoms. Of these studies, 59 had a cross-sectional design (35 case-control studies and 24 cohort studies), and 8 had a longitudinal design (8 cohort studies). In total, data from 43 600 participants, including 9203 individuals (21.1%) with depression, were included in the meta-analysis. The mean age of participants was 66 years, and 23 544 were female (54.0%). In total, 72 441 person-years were included in longitudinal analyses (mean [SD] follow-up, 3.7 [0.7] years). We found no studies that investigated the association between skin and muscle microcirculation and depressive disorder or depressive symptoms. All studies included in the review used a dichotomous outcome measure for depression, either by use of a diagnostic interview to assess major depressive disorder or by use of a cutoff for clinically relevant depressive symptoms, including the Mini International Neuropsychiatric Interview or the Structured Clinical Interview for DSM for depressive disorder and the Centers for Epidemiological Studies Depression Scale, the Geriatric Depression Scale, the Hamilton Depression Rating Scale, the Beck Depression Inventory, and the Montgomery-Asberg Depression Rating Scale for clinically relevant depressive symptoms. Plasma samples of biomarkers (soluble intercellular adhesion molecule-1 [sICAM-1], soluble vascular cell adhesion molecule-1 [sVCAM-1], e-selectin, and von Willebrand factor [vWF] ) for endothelial function were all analyzed by the use of an enzyme-linked immunosorbent assay. Albuminuria was measured by use of the albumin to creatinine ratio or 24-hour urinary albumin excretion. Retinal vessel calibers were measured by the use of stereoscopic color fundus photography. Cerebral small vessel disease was determined by magnetic resonance imaging-defined automated segmentation of WMH volume (33 studies), rating scales for WMH severity (22 studies), microbleeds (4 studies), and/or lacunar or silent infarctions (4 studies). Characteristics of all selected studies are presented in eTable 2 in the Supplement and the outcomes of the selected studies in eTable 3 in the Supplement.
Association of Endothelial Function With Depression
Eight studies investigated the cross-sectional associations between plasma markers of endothelial function and depressive symptoms (n = 6) or depressive disorder (n = 4). 21, [32] [33] [34] [35] [36] [37] [38] Most studies observed that higher levels of endothelial plasma markers, which indicate dysfunction, were associated with depression. 32, 33, [35] [36] [37] [38] One study described lower sVCAM-1 levels, 34 and another study lower e-selectin levels, 21 in participants with depression compared with controls without depression. Seven studies 21, [32] [33] [34] [35] 37, 38 were included in the metaanalysis on plasma markers of endothelial function (1 study provided insufficient data 36 ). We found a significant association between higher levels of plasma markers of endothelial function and depression ( Figure 2 ; pooled OR per SD increase 
Association of Albuminuria With Depression
Two studies investigated the association between albuminuria and depression. 22 venular diameter 209.9 [7.9] ; P = .03 for trend). 39 In contrast, a large longitudinal cohort study found no association between retinal arteriolar and venular diameters and incident major depressive disorder during 9 years of follow-up (hazard ratio per SD increase in arteriolar diameter, 1.01; 95% CI, 0.93-1.10; and hazard ratio per SD increase in venular diameter, 1.02; 95% CI, 0.94-1.12).
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Cross-Sectional Association of Cerebral Small Vessel Disease With Depression
Fifty-five studies investigated the association between cerebral small vessel disease and depression, 11, 13, 14, 17, 20, of which 8 studies had a prospective design. 13, 20, 70, 84, 85, [88] [89] [90] Most studies focused on WMH volumes or WMH severity scores in a casecontrol or a population-based cohort setting. In addition to studying WMHs, 4 studies also evaluated the association of microbleeds and microinfarctions with depression. 13, 51, 82, 91 Overall, cerebral small vessel disease was associated with depression. Thirty-eight studies 11, 13, 17, [44] [45] [46] [47] 49, [51] [52] [53] [54] [55] [56] [57] [58] [60] [61] [62] [63] [64] 66, 73, [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] 91 were included in the meta-analysis on cross-sectional data ( Figure 3 ; eFigure 2 and eFigure 3 in the Supplement Chen et al, 45 2009
Colloby et al, 46 2011
Cyprien et al, 47 2014
De Groot et al, 11 2000
Delaloye et al, 49 Twenty-two studies used questionnaires to assess depressive symptoms; pooling of these studies resulted in an OR of 1.24 per SD (95% CI, 1.14-1.35; P < .001; 
Longitudinal Association of Cerebral Small Vessel Disease With Depression
Eight studies were included in the meta-analysis of longitudinal data ( Figure 4) . 13, 20, 70, 84, 85, [88] [89] [90] Only data on WMHs could be pooled, because only 1 longitudinal study 13 investigated the association of microbleeds and brain infarctions with depression. As shown in Figure 4 , a statistically significant association between WMHs and the incidence of depression was found (pooled OR, 1.18; 95% CI, 1.08-1.28; P < .001; I 2 = 27%) over a mean follow-up of 3.7 years. We found no evidence of publication bias based on the funnel plots (eFigure 5 in the Supplement) or the Egger test (t = 1.139; P = .30).
Discussion
This extensive meta-analysis on 43 600 participants, including 9203 individuals with depression, shows that generalized microvascular dysfunction is associated with depression, both in cross-sectional and longitudinal settings, independent of cardiovascular risk factors. Multiple markers of microvascular dysfunction, including endothelial plasma markers and markers of cerebral small vessel disease, are crosssectionally associated with a higher level of depressive symptoms and depressive disorder. In addition, WMHs are associated with incident depression over time. These findings are in agreement with the vascular depression hypothesis and extend this hypothesis, as peripheral microvascular dysfunction may also be associated with depression.
92,93
In this systematic review with meta-analysis, we evaluated the associations between microvascular dysfunction and depression. We included cross-sectional and longitudinal epidemiologic studies, and are the first, to our knowledge, to consider the association of multiple measures of both cerebral and peripheral microvascular dysfunction with depression. By combining the extensive evidence on WMHs with data from biomarkers of endothelial function, we aim to provide further evidence for the hypothesis that cerebral small vessel disease may originate from endothelial dysfunction. We suggest that generalized microvascular dysfunction, as can be measured throughout the body, is an important pathophysiologic factor that may contribute to the development of depression. Our van Sloten et al, 13 results confirm and extend 2 previous meta-analyses that addressed the association between WMHs and depression 19, 94 by including more than 6 times the number of participants and depression cases, thus increasing statistical power. This number enabled us to overcome the major caveat of high heterogeneity, which was a major methodological issue in previous meta-analyses. The use of diagnostic interviews vs questionnaires to assess depression, and case-control vs cohort study design were found to be the sources of heterogeneity, which has important implications for future studies that investigate the pathophysiologic factors of depression. These variables, however, did not affect the observed associations, which strengthens the validity of our findings. Finally, our study focused on late-life depression, in which vascular pathologic conditions are thought to have the greatest effect, while previous meta-analyses combined early and late-life depression.
19,94
The association of microvascular dysfunction with depression can be explained by several mechanisms. First, impaired endothelial function in the cerebral microcirculation may lead to cerebral perfusion deficits, resulting in chronic ischemia in the cerebrum. 95 Chronic ischemia could cause structural disruptions of the fiber tracts in the cerebral white matter, which are visualized as WMHs on results of magnetic resonance imaging. [95] [96] [97] [98] If the affected regions are involved in mood regulation, this may predispose the individual to the development of depression. Second, microvascular dysfunction is closely linked to and interrelated with chronic low-grade inflammation and/or oxidative stress, which may represent different pathways in the development of depression. 35 ,99-102 Low-grade inflammation is known to contribute to endothelial dysfunction. 21, 35 In addition, the cerebral endothelium may be more vulnerable to oxidative stress, owing to a high production of reactive oxygen species in the brain as a result of the high metabolic demand. 103 Moreover, the brain has limited antioxidant defenses, 104 while damage related to oxidative stress has been described in psychiatric disease [105] [106] [107] and may contribute to cerebral dysfunction. However, multiple studies have shown that the association between microvascular dysfunction and depression is only partly dependent on inflammation 21, 35, 36 or oxidative stress, 21 which suggests that microvascular dysfunction itself represents an independent pathway in the development of depression. Third, cardiometabolic risk factors may be involved in the association between microvascular dysfunction and depression. For instance, increased arterial stiffening may induce microvascular disease and is related to depression. 108 Increased arterial stiffness leads to an increased pulsatile pressure load, which, owing to the low impedance of the cerebral microcirculation, can penetrate deeply into the white matter, thereby inducing microvascular dysfunction and WMHs. 
Strengths and Limitations
The strengths of this study include the large number of included studies and individuals with depression, resulting in high statistical power, which allowed an extensive exploration of the cause of heterogeneity within the meta-analysis. This meta-analysis is limited by the available literature. Based on the available data, we cannot rule out the possibility of reverse causality. It is plausible to assume that the association between microvascular dysfunction and depression is bidirectional; that is, microvascular dysfunction may cause depression, and vice versa. The proposed temporality was supported by the longitudinal association for WMHs and depression, but could not be confirmed for other markers of microvascular dysfunction. Further longitudinal studies are needed to address this issue. In addition, the interrelationships among medical comorbidities, microvascular dysfunction, and depression could only partly be assessed. Therefore, an important limitation of this meta-analysis and indeed of the source studies is that we cannot exclude residual confounding by variables not considered in the source studies. However, based on our subanalyses, confounding by type 2 diabetes, hypertension, and cardiovascular risk factors is unlikely. In addition, some of the indicators of vascular dysfunction, such as albuminuria, may be less specific and may more likely reflect a general health status, which could have led to an overestimation of the association. Furthermore, most studies on plasma biomarkers of endothelial dysfunction measured multiple biomarkers; therefore, we did not calculate a pooled estimate. Nevertheless, when focusing on the pooled ORs per specific biomarker, the 95% CIs were virtually within the same range. Finally, data on the association between albuminuria, retinal diameters, and depression appeared to be scarce, while data on albuminuria were available only in study populations with disease, and therefore cannot be extrapolated to the general population. As the cerebral microvasculature is difficult to study, there is a need to develop more advanced and powerful imaging techniques, such as 7-T magnetic resonance imaging and diffuse tensor imaging, which may provide more sensitive research tools with more detailed structural information on microvascular changes as seen in cerebral small vessel disease. 
Conclusions
This meta-analysis shows that generalized microvascular dysfunction is associated with higher odds of depression and that cerebral small vessel disease is associated with an increased risk for the development of depression over time. These findings support the hypothesis that microvascular dysfunction is causally linked to depression. This finding may have clinical implications, as microvascular dysfunction might provide a potential target for the prevention and treatment of depression. This supplementary material has been provided by the authors to give readers additional information about their work.
eAppendix. Search Terms Used for the Systematic Review and Meta-analysis
We used the following terms to systematically search the current literature: "depression" OR "depressive disorder" OR "depress*[Title]" AND 1) "sICAM-1" OR "sVCAM-1"OR "sE-selectin" OR "vWF" AND 2a) "capillary recruitment" OR "capillaroscopy" OR "laser-Doppler flowmetry" OR "capillaries" AND 2b) "L-NMMA" OR "sodium nitroprusside" OR "plethysmography" OR "forearm blood flow" OR "iontophoresis" OR "intracutaneous injection" AND 3) "urinary albumin excretion" OR "albuminuria" OR "macroalbuminuria" OR "microalbuminuria" AND 4) "retinal arteriolar diameter" OR "retinal venular diameter" OR "arteriovenous ratio" OR "retinal vessels" AND 5) "cerebral small vessel disease" OR "CSVD" OR "white matter lesion" OR "WML" OR "microbleeds" OR "microinfarctions" OR "lacunar infarctions". The references of the identified studies were checked in order to identify additional relevant articles. The search was limited to humans and study populations aged >40 years. 
